To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients

Clinical trial NCT01755429 · COMPLETED

Trial details

NCT number: NCT01755429
Sponsor: Alexion Pharmaceuticals, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS)

Start date: 2012-05-01
Primary completion: 2012-05-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.